Retension offers VP CAO role to Robert Wong
Retension Pharmaceuticals has offered the position of Vice President, Chief Accounting Officer to Robert Wong, effective November 2, 2026. The offer includes a base salary of $360,000 and standard equity compensation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed